4 Izifo Zemvelo Zesifo Se-Rheumatoid Arthritis

I-arthritis ye-rumatoid yisimo sokuvuvukala esibangela ubuhlungu nokuvuvukala kwamajoyina, ikakhulukazi amalunga amancane ezandla nezinyawo. Ngokuvamile kuthinta zombili izinhlangothi zomzimba ngesikhathi esifanayo.

Ezinye izimpawu ze-arthritis ye-rhumum is:

I-arthritis ye-rheumatoid iyakholelwa ukuthi iyisifo esizimele, okuholela ekubeni isimiso somzimba sokuvikela omzimba sihlasele izicubu ezihlanganisa amalunga.

Izifo Zemvelo Ze-Rheumatoid Arthritis

Ayikho ikhambi eyaziwayo yesifo se-rheumatoid arthritis. Ezinye izindlela zokwelapha zithandwa kubantu abane-arthritis ye-rheumatoid, Nokho, kufanele bahlanganise, hhayi ukufaka indawo, ukunakekelwa okujwayelekile. Nazi ezinye izindlela zemvelo ezisetshenziselwa isifo samathambo.

1) i-Omega-3 Fatty Acids

Ama-omega-3 fatty acids ayinhlobo lamafutha. Imizimba yethu ayikwazi ukwenza i-omega-3s yedwa, ngakho-ke kufanele siyithole ngokudla kwethu.

Kukhona ubufakazi obunamandla bokuthi ama-fatty acids ama-omega-3 angasiza abantu abane-arthritis ye-rheumatoid. Imiphumela yezibalo ezingaphezu kwezingu-13 eziphambene nezimpumputhe, ezilawulwa yi-placebo ezibandakanya inani labantu abangaphezu kuka-500 ziphakamisa ukuthi i-omega-3 fatty acids ingathuthukisa izimpawu zesifo samathambo.

Enye yezindlela ezibonakala sengathi ziyasebenza ukunciphisa ukukhiqizwa kwamakhemikhali abhubhisa.

Nakuba ama-fatty acids e-omega-3 anciphisa izimpawu zesifo samathambo, asibonakali ukuphuza ukuqhubeka kwesifo.

Izinhlanzi zamanzi ezinwabuzelayo njenge-salmon, ama-sardine nama-anchovies yiwona odla kakhulu omega-3 fatty acids.

Kodwa esikhundleni sokudla izinhlanzi eziningi eziqukethe i-mercury, i-PCBs, namanye amakhemikhali, ama-capsules ama-fish fish kubhekwa njengomthombo ohlanzekile wama-omega-3 fatty acids. Izinkampani eziningi zihlunga amafutha abo enhlanzi ukuze lezi zimakhemikhali zisuswe.

Ama-capsules amafutha wezinhlanzi athengiswa ezitolo zokudla ezempilo, ezitolo zezidakamizwa nase-intanethi. Ama-brand amaningi kufanele agcinwe efrijini ukuvimbela amafutha ukuba angene e-rancid.

Nakuba amafutha ashukela evame ukusetshenziselwa njengendlela ehlukile yokudoba amafutha, akubonakali ukuthi anomphumela ofanayo wokuvuvukala njengamafutha enhlanzi ekufakeni okufinyelelekayo.

Ama-capsules amafutha wezinhlanzi angase ahlanganyele nezidakamizwa ezithwala igazi ezifana ne-warfarin ne-aspirin. Imiphumela emibi ingafaka indigestion negazi. Amafutha okudoba akufanele athathwe amasonto amabili ngaphambi kokuhlinzwa noma ngemuva kokuhlinzwa. Amafutha wezinhlanzi angabangela futhi emva kwe-fishy aftertaste. Ukuvimbela lokhu, amafutha wezinhlanzi ngokuvamile athathwa ngaphambi kokudla.

2) I-Acid Gamin-linolenic Acid

Nakuba kukhona ubufakazi obengeziwe bokuthi ama-fatty acids ama-omega-3 angathuthukisa izimpawu zesifo samathambo, ezinye izifundo zibonisa ukuthi i-gamma-linoleic acid, enye uhlobo lwe-fatty acid ebalulekile, ingasiza. Itholakala kumafutha we-borage , ama- black currant imbewu yamafutha , namafutha omhlaba wokuhlwa .

Ukubuyekezwa kokucwaninga kwabacwaningi abaneCorgan Research Collaboration ehlonishwayo kwaphetha ngokuthi kwakukhona inzuzo engaba khona ekusebenziseni i-gamma-linolenic acid e-rheumatoid arthritis, nakuba kwakudingeka izifundo eziqhubekayo.

3) i-Boswellia

I-Boswellia iyimifino evela esihlahleni esivela eNdiya. Izithako ezisebenzayo yizikhali ze-boswellic, ezitholakale zivimbela ukusabela kwamakhemikhali okuhilelekile ekuvuvukala.

Isetshenziswa abantu abane-arthritis ye-rheumatoid nezinye izimo zokuvuvukala . Nakuba kuye kwaba nezifundo ezimbalwa zokuqala ezibonisa ukuthi i-boswellia inganciphisa izimpawu zesifo samathambo, sidinga ucwaningo olwengeziwe ukuze sithole ukuthi lusebenza yini. Akukho ubufakazi bokuthi kunganciphisa ukuqhubekela phambili kwesifo njengamanye amadakamizwa avamile we-arthritis ye-rheumatoid.

I-Boswellia ayibonakali ibangela ukucasuka kwamathumba okungahle kwenzeke ngokukhululeka okuvamile okubuhlungu.

I-Boswellia iyatholakala efomini lepilisi. Kumele ithi kulelebula ukuthi ilunganiselwe ukuba iqukathe ama-acid we-acellic acid angu-60. Akufanele kuthathwe amasonto angaphezu kweyisishiyagalolunye kuya kwangu-12 ngaphandle kokuqondiswa komsebenzi wezempilo oqeqeshiwe.

4) Isihluthulelo sikaDeveli

Uhlombe lukaDeveli luyisitshalo esivela eningizimu ye-Afrika. Igama layo livela ezitsheni ezincane ezitshalweni zezitshalo. Izithako ezisebenzayo ekugqobeni kukaSathane zikholakala ukuthi ziyi-glycosides ye-iridoid ebizwa nge-harpagosides, etholakala emthonjeni wesibili.

Uzipho lukaDeveli luye lwasetshenziswa iminyaka eyizinkulungwane e-Afrika ngenxa yomkhuhlane, isifo samathambo, izimo zesikhumba, nezimo ezibandakanya i-gallbladder, i-pancreas, isisu, nezinso.

Ucwaningo olunyatheliswa emaphepheni I-Rheumatology liqhathanisa ukukhishwa kwesikhumba sikaDeveli ukuhlinzeka ngama-harpagosides angu-60 ngosuku kanye no-12.5 mg ngosuku lweVixx eyimpi (manje esemakethe) emasontweni ayisithupha kuya kweziguli ezingu-79 ezinezikhukhula ezibuhlungu zokubuya emuva. Uhlombe lukaDeveli lwaluphumelela njengoVixx ekunciphiseni ubuhlungu.

Izifundo ezengeziwe, noma kunjalo, ziyadingeka ngaphambi kokuba siqinisekise ukuthi ukuhlunga kukaDeveli kuyasebenza ngosifo samathambo e-rheumatoid. Ukuze uthole ukwaziswa okwengeziwe mayelana nokuhlunga kukaDeveli, funda iShidi Lamaqiniso KaKhisimusi .

Ezinye iziLungiso eziPhakanyisiwe

> Imithombo:

> Fritsche K. Fatty Acids njengeModulators ye-Immune Response. I-Annu Rev Nutriti. 26 (2006): 45-73.

> Lee S, Gura KM, Kim S, Arsenault DA, BR Brian, Puder M. Izicelo zamanje zemizimba ye-omega-6 nama-omega-3 fatty acids. I-Clinic Pract. 21.4 (2006): 323-341.

> Remans PH, JK, Wagenaar LW, Wouters-Wesseling W, Zuijderduin WM, Jongma A, Breedveld FC, Van Laar JM. I-Supplementation Yomdlavuza Ne-Polyunsaturated Fatty Acids nama-Micronutrients e-Rheumatoid Arthritis: Imiphumela Yomtholampilo Nezibalo Zezinto Eziphilayo. I-Eur J Clin Nutriti. 58.6 (2004): 839-845.

> Soeken KL, Miller SA, Ernst E. Herbal Imithi yokwelashwa kwe-Rheumatoid Arthritis: Ukubuyekezwa okuhlelekile. I-Rheumatology (i-Oxford). 42.5 (2003): 652-659.